ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för LY-2183240. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

14 träffar

Bibliografisk träff 2023-03-07

Library Screening and Preliminary Characterization of Synthetic Cannabinoids Against Prostate and Pancreatic Cancer Cell Lines.

Karelia D, Corey Z, Wang H, Raup-Konsavage WM, Vrana KE, Lü J, Jiang C.

Cannabis Cannabinoid Res · research support, non-u.s. gov't; journal article · DOI 10.1089/can.2022.0270

Bibliografisk träff 2023-03-07

LY2183240 regioisomers act as competitive and selective inhibitors of class C β-lactamases.

de Resende PE, Soares S, Zloh M, Gibbons S, Stapleton P.

Int J Antimicrob Agents · journal article · DOI 10.1016/j.ijantimicag.2023.106774

Bibliografisk träff 2018-03-04

Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures.

Zareie P, Sadegh M, Palizvan MR, Moradi-Chameh H.

Metab Brain Dis · research support, non-u.s. gov't; journal article · DOI 10.1007/s11011-018-0195-5

Bibliografisk träff 2017-08-24

Arvanil, olvanil, AM 1172 and LY 2183240 (various cannabinoid CB1 receptor agonists) increase the threshold for maximal electroshock-induced seizures in mice.

Tutka P, Wlaź A, Florek-Łuszczki M, Kołodziejczyk P, Bartusik-Aebisher D, Łuszczki JJ.

Pharmacol Rep · comparative study; journal article · DOI 10.1016/j.pharep.2017.08.006

Bibliografisk träff 2017-01-20

Endocannabinoid activation of CB<sub>1</sub> receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation.

Sun L, Tai L, Qiu Q, Mitchell R, Fleetwood-Walker S, Joosten EA, Cheung CW.

Eur J Pain · journal article · DOI 10.1002/ejp.983

Bibliografisk träff 2015-06-27

Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists.

Veeraraghavan P, Nistri A.

Neuroscience · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuroscience.2015.06.045

Bibliografisk träff 2014-03-27

Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products.

Uchiyama N, Matsuda S, Kawamura M, Shimokawa Y, Kikura-Hanajiri R, Aritake K, Urade Y, Goda Y.

Forensic Sci Int · journal article · DOI 10.1016/j.forsciint.2014.03.013

Bibliografisk träff 2010-09-14

Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference.

Powers MS, Barrenha GD, Mlinac NS, Barker EL, Chester JA.

Psychopharmacology (Berl) · research-article; journal article; research support, n.i.h., extramural · DOI 10.1007/s00213-010-1997-2

Bibliografisk träff 2008-11-11

The endocannabinoid anandamide inhibits kinin B1 receptor sensitization through cannabinoid CB1 receptor stimulation in human umbilical vein.

Pelorosso FG, Gago JE, Del Rey G, Menéndez SD, Errasti AE, Rothlin RP.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2008.10.058

Bibliografisk träff 2008-07-28

Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms.

Maione S, Morera E, Marabese I, Ligresti A, Luongo L, Ortar G, Di Marzo V.

Br J Pharmacol · other; journal article · DOI 10.1038/bjp.2008.308

Bibliografisk träff 2008-05-14

Aqueous humor outflow effects of 2-arachidonylglycerol.

Njie YF, He F, Qiao Z, Song ZH.

Exp Eye Res · journal article; research support, n.i.h., extramural · DOI 10.1016/j.exer.2008.05.003

Bibliografisk träff 2007-03-19

Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation.

Ortar G, Cascio MG, Moriello AS, Camalli M, Morera E, Nalli M, Di Marzo V.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2007.02.023

Bibliografisk träff 2006-08-01

The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases.

Alexander JP, Cravatt BF.

J Am Chem Soc · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1021/ja062999h

Bibliografisk träff 2006-05-31

Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.

Dickason-Chesterfield AK, Kidd SR, Moore SA, Schaus JM, Liu B, Nomikos GG, Felder CC.

Cell Mol Neurobiol · comparative study; research-article; evaluation study; journal article · DOI 10.1007/s10571-006-9072-6